This antibody may provide a therapeutic agent and a therapeutic method for cancers including neuroblastoma, pulmonary cancer, mammary cancer, etc. Another purpose this product is to provide a cancer diagnostic agent and an imaging agent.
Figure 1 A is a SY5Y-ctrl, B is a result of SY5Y-N1.
It shows cell growth inhibitory effect of anti NLRR1 monoclonal antibody (NLRR1 mAb # 281-6) in NB and non NB cells.
Figure 2 It shows that the treatment with N1mAb antibody (# 281-6) was significantly inhibited the growth of xenograft tumors.
Open circles are saline, the black circles is an antibody.
Figure 3 It shows that the treatment with N1mAb antibody (# 281-6) was significantly inhibited the growth of xenograft tumors.
Open circles are saline, the black circles is an antibody.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-522MZ | Anti-Human LRRN1 Recombinant Antibody (TB0777#281-6 (N1mAb)) | ELISA, FC | |
TAB-522MZ-F(E) | Anti-Human LRRN1 Recombinant Antibody Fab Fragment (TB0777#281-6 (N1mAb)) | ELISA, FC |
There are currently no Customer reviews or questions for TAB-522MZ-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.